Transdermal drug delivery formulation

Details Transdermal drug delivery formulation Transdermal drug delivery formulation

A - Human Necessities

61

K

A61K 9/70 (2006.01) A61K 31/196 (2006.01) A61K 47/14 (2006.01) A61K 47/20 (2006.01)

Patent

CA 2617934

The present invention provides a transdermal formulation for the delivery of at least one active agent. The formulation includes (i) a first compound comprising an organic sulfoxide, and (ii) a second compound selected from the group consisting of a fatty acid ester, a fatty acid, an azone-related compound and mixtures thereof.

La présente invention concerne une formulation transdermique pour l'administration d'un ou plusieurs agents actifs. La formulation comprend (i) un premier composé comprenant un sulfoxyde organique, et (ii) un second composé sélectionné parmi le groupe constitué par un ester d'acide gras, un acide gras, un composé lié à l'ozone et des mélanges de ces composés.

Affiliated with

Also associated with

Rating

Transdermal drug delivery formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal drug delivery formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal drug delivery formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1345648